AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 APR 21 - (NewsRx.com & NewsRx.net) -- Scientists review bacteria-mediated DNA transfer in gene therapy and vaccination in a recent issue of Expert Opinion on Biological Therapy.
According to researchers in Germany, "The use of live attenuated bacterial vaccine strains allows the targeted delivery of macromolecules to mammalian cells and tissues via the mucosal route. Depending on their specific virulence mechanisms and inherent metabolic preferences, bacteria invade certain cell types and body niches where they consequently deliver their cargo. Recently, the ability of attenuated strains of Salmonella, Shigella, and Yersinia species, as well as Listeria monocytogenes and invasive Escherichia coli, to deliver eukaryotic expression plasmids into mammalian cells in vitro and in vivo has been discovered."
"The great potential of bacteria-mediated transfer of plasmid DNA encoding vaccine antigens and/or therapeutic molecules was demonstrated in experimental animal models of infectious diseases, tumors, and gene deficiencies," stated Holger Loessner and Siegfried Weiss at the German Research Center for Biotechnology in Braunschweig. ...